| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019382 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 02/14/2002 | US20020018955 For thermally processed image recording material having high sensitivity, antifogging properties, stock sensitivity, and storage stability; may be used as polymerization catalyst |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/12/2002 | CA2057410C Astaxanthin intermediates |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010125A1 Crystalline and pure modafinil, and process of preparing the same |
| 02/07/2002 | WO2001000566A3 Substituted phenoxyacetic acids |
| 02/07/2002 | US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | US20020016311 Nitrate esters and their use for neurological conditions |
| 02/07/2002 | DE10037146A1 Acetamidderivate Acetamide derivatives |
| 02/07/2002 | DE10036852A1 Urethanderivate Urethane |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 02/06/2002 | EP0874810B1 Method for purifying dimethyl sulphoxide (dmso) |
| 02/06/2002 | EP0790824B1 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance |
| 02/06/2002 | EP0772598B1 Preparation of heterocyclic- and carbocyclic-substituted benzoic acids |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/06/2002 | CN1078887C Sulfur-contg. di-tert-bytylphenol compounds useful as anti-inflammatory agents |
| 02/05/2002 | US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/05/2002 | US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis |
| 01/31/2002 | WO2002008209A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 01/31/2002 | US20020013498 Reduction of the corresponding nitrile containing compound |
| 01/31/2002 | US20020013497 Alkylation, blocking |
| 01/31/2002 | US20020013493 Process for preparing a sulfinate |
| 01/31/2002 | US20020013370 Methods for identifying and treating resistant tumors |
| 01/30/2002 | EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
| 01/30/2002 | CN1078586C Phenylalkanamide derivatives and agrohor-ticultural bactericides |
| 01/29/2002 | US6342639 Processes for preparing 3-Arylsulfur hydroxamic acids |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/29/2002 | US6342496 Bupropion metabolites and methods of use |
| 01/29/2002 | CA2145296C Benzenealkanoic acids for cardiovascular diseases |
| 01/24/2002 | WO2002006215A1 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivates |
| 01/24/2002 | WO2002005954A1 Composition and compound based on metal and acid salt(s) having a sulphonyl group borne by a perhalogenated carbon and their use as lewis acid |
| 01/24/2002 | US20020010214 Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension |
| 01/24/2002 | US20020010213 Inhibiting membrane transport mediated by the multidrug resistance associated protein MRP in a patient by administering a compound having an amphiphilic anion and a molecular weight of from 300 to 950 daltons. |
| 01/24/2002 | US20020009663 Positive or negative amplification |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | US20020009635 Novel materials for use as electrolytic solutes |
| 01/23/2002 | EP1174028A1 Sulfonamide derivatives |
| 01/23/2002 | EP1173417A1 Process and apparatus for making ultra-pure dmso |
| 01/23/2002 | EP1173416A1 Method for purifying methanide electrolytes (ii) |
| 01/23/2002 | EP1173161A2 Glucamine compounds for treating hepatitis virus infections |
| 01/23/2002 | EP1173160A1 (e)-styryl sulfone anticancer agents |
| 01/23/2002 | EP0968177B1 Method for producing aromatic nitriles |
| 01/23/2002 | EP0904269B1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 01/23/2002 | CN1078204C Amino acid amide derivative and fungicidal use and production process thereof |
| 01/22/2002 | US6340691 Treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 01/22/2002 | CA2024956C Isoxazoles herbicides |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/16/2002 | EP0996606B1 Catalysed fluorination of carbonyl compounds |
| 01/16/2002 | EP0906300B1 Process for making phenyl heterocycles useful as cox-2 inhibitors |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/16/2002 | CN1331675A Novel herbicides |
| 01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002515A1 Hydrazone derivatives effective in pest control or salts thereof |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | US20020004614 Method for making dimethyl sulfone from dimethyl sulfoxide and hydrogen peroxide |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170290A2 Compounds having ultra-violet absorption properties |
| 01/09/2002 | EP1170285A1 A process for preparing a sulfinate |
| 01/09/2002 | EP1169312A2 Glucokinase activators |
| 01/09/2002 | EP1169301A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/09/2002 | CN1330593A Heat sensitive recording material |
| 01/09/2002 | CN1330071A Synthetic method for benzo [b] thiophene derivative |
| 01/08/2002 | US6337328 Bupropion metabolites and methods of use |
| 01/08/2002 | US6337306 Herbicides for agriculture |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | WO2002000602A1 Benzophenones and sulfones as inhibitors of glycine uptake |
| 01/03/2002 | WO2002000590A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 01/03/2002 | WO2002000167A2 Modified forms of pharmacologically active agents and uses therefor |
| 01/03/2002 | US20020002190 Antidiabetic agents increasing the expression of glucokinase (GK) to improve glucose tolerance; increase in glucose exposure coupled through GK in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 01/03/2002 | US20020002183 Benzamides and related inhibitors of factor Xa |
| 01/03/2002 | CA2414150A1 Modified forms of nonsteroidal anti-inflammatory drugs and uses thereof |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/02/2002 | EP1165662A1 Manufacture of polysulfones |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165502A1 Diaryl derivatives and their use as medicaments |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165495A1 Resorcinol derivatives |
| 01/02/2002 | EP1165086A2 Bupropion metabolites and methods of their synthesis and use |
| 01/02/2002 | CN1329281A Colour photosensitive imaging element containing closed developer |
| 01/01/2002 | US6335462 Polymerizable oligomesogenes |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335366 A prostaglandin e2 antagonist or agonist which comprises a naphthylhydroxy derivatives or naphthyloxyalkylene derivatives or nontoxic salts |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 12/27/2001 | US20010056188 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |